Lndoleamine 2, 3-dioxygenase activity during fulvestrant therapy for aromatase inhibitor resistant metastatic breast cancer

Kenichi Sakurai, Shigeru Fujisaki, Hitomi Kubota, Yukiko Hara, Shuhei Suzuki, Keita Adachi, Ryouichi Tomita, Katsuhisa Enomoto, Tomohiro Hirano, Reina Saga, Makoto Makishima

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Lndoleamine 2, 3-dioxygenase activity during fulvestrant therapy for aromatase inhibitor resistant metastatic breast cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science